Therapy Evaluation: T2DM, HTN, Dyslipidaemia, CKD

NP Certification Q&A

The NP is caring for a 68 year-old man with a 20 year-history of  type 2 DM, HTN, dyslipidaemia, obesity (BMI=32 kg/m2) stage 3a CKD who is currently taking all of the following medications at optimized doses and with adherence, ACEI, thiazide diuretic, statin, and metformin. His current A1c= 8.2%. (NL= <5-6%)  and states he is feeling well. Which of the following should be considered as next step therapy?

A. A sulfonylurea

B. Basal insulin

C. A SGLT2- inhibitor 

D. No additional therapy as he is feeling well.

---
YouTube: https://www.youtube.com/watch?v=SF_ztpgR_Tw&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=14

Visit fhea.com to learn more!

More description

The NP is caring for a 68 year-old man with a 20 year-history of  type 2 DM, HTN, dyslipidaemia, obesity (BMI=32 kg/m2) stage 3a CKD who is currently taking all of the following medications at optimized doses and with adherence, ACEI, thiazide diuretic, statin, and metformin. His current A1c= 8.2%. (NL= <5-6%)  and states he is feeling well. Which of the following should be considered as next step therapy?

A. A sulfonylurea

B. Basal insulin

C. A SGLT2- inhibitor 

D. No additional therapy as he is feeling well.

---
YouTube: https://www.youtube.com/watch?v=SF_ztpgR_Tw&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=14

Visit fhea.com to learn more!

2023-04-17 10 min Transcript
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.